Neuroendocrine effects of electroconvulsive therapy (ECT)

Area of Science:

• Neuroendocrinology
• Psychiatry
• Clinical Neurophysiology

Background:

• Accurate measurement of hormone release during electroconvulsive therapy (ECT) is crucial.
• Hormone levels can be influenced by various physiological processes, potentially obscuring ECT-induced changes.
• Understanding these neuroendocrine responses aids in elucidating ECT's mechanisms and optimizing its application.

Purpose of the Study:

• To review the principles and challenges in observing ECT-induced hormone release.
• To describe the clinical applicability and limitations of measuring specific hormones (prolactin, cortisol, oxytocin, vasopressin).
• To explore the potential of neuroendocrine measurements in understanding ECT physiology, seizure quality, technique comparison, illness severity, and predicting treatment response.

Main Methods:

• Review of existing literature on neuroendocrine responses to ECT.
• Discussion of methodological considerations for hormone level measurements.
• Analysis of the clinical relevance of various hormone assays in the context of ECT.

Main Results:

• ECT influences the release of several hormones, including prolactin, cortisol, oxytocin, and vasopressin.
• Factors other than ECT can significantly alter hormone levels, necessitating careful experimental design.
• Measurements can inform ECT physiology, seizure characteristics, and illness severity.

Conclusions:

• Careful consideration of confounding factors is essential for reliable ECT-induced hormone release observation.
• Neuroendocrine measurements offer valuable insights into ECT's effects and clinical applications.
• Predicting ECT response stability using neuroendocrine markers remains an underutilized but promising area.